Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reid C Thompson

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Cytometry. Part B, Clinical Cytometry|September 7, 2016
Single cell analysis of human tissues and solid tumors with mass cytometryNalin Leelatian, Deon B Doxie, Allison R Greenplate, et al.
NMR in Biomedicine|September 30, 2025
Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate and Glycine in Adult Subjects With Brainstem GliomasVivek Tiwari, Sandeep K Ganji, Zhongxu An, et al.
Neurosurgery|August 11, 2016
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle StudyAdam M Sonabend, Brad E Zacharia, Michael B Cloney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
SSBP2 variants are associated with survival in glioblastoma patientsYuanyuan Xiao, Paul A Decker, Terri Rice, et al.
International Journal of Cancer|April 10, 2019
Glioma risk associated with extent of estimated European genetic ancestry in African Americans and HispanicsQuinn T Ostrom, Kathleen M Egan, L Burt Nabors, et al.
Journal of Translational Medicine|July 1, 2018
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.
Journal of Translational Medicine|May 31, 2018
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.
Nature Genetics|January 3, 2025
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lipJohn J Y Lee, Ran Tao, Zhen You, et al.
JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Cytometry. Part B, Clinical Cytometry|September 7, 2016
Single cell analysis of human tissues and solid tumors with mass cytometryNalin Leelatian, Deon B Doxie, Allison R Greenplate, et al.
NMR in Biomedicine|September 30, 2025
Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate and Glycine in Adult Subjects With Brainstem GliomasVivek Tiwari, Sandeep K Ganji, Zhongxu An, et al.
Neurosurgery|August 11, 2016
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle StudyAdam M Sonabend, Brad E Zacharia, Michael B Cloney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
SSBP2 variants are associated with survival in glioblastoma patientsYuanyuan Xiao, Paul A Decker, Terri Rice, et al.
International Journal of Cancer|April 10, 2019
Glioma risk associated with extent of estimated European genetic ancestry in African Americans and HispanicsQuinn T Ostrom, Kathleen M Egan, L Burt Nabors, et al.
Journal of Translational Medicine|July 1, 2018
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.
Journal of Translational Medicine|May 31, 2018
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.
Nature Genetics|January 3, 2025
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lipJohn J Y Lee, Ran Tao, Zhen You, et al.
JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Pageof 16